Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × dexamethasone acetate × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 9 Burkitt Lymphoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Biphenotypic, Acute 3 Recurrence 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Neoplasm Metastasis 2 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Fatigue 1 Down Syndrome 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

Magnetic Resonance Spectroscopy 27 Specimen Handling 26 enzalutamide 23 Prednisone 22 Abiraterone Acetate 19 apalutamide 17 Androgen Antagonists 17 darolutamide 13 Leuprolide 12 Radiotherapy 10 Pluvicto 10 Radiosurgery 9 Biopsy 9 cabazitaxel 8 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8 abiraterone 8 X-Rays 8 Goserelin 8 bicalutamide 7 Photons 7 Docetaxel 7 relugolix 6 prednylidene 6 luprolide acetate gel depot 6 gallium 68 PSMA-11 6 deltacortene 6 Triptorelin Pamoate 6 Gonadotropin-Releasing Hormone 6 Glutamate Carboxypeptidase II 6 Brachytherapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06136598 2026-02-17

MK-5684-001

Merck Sharp & Dohme LLC

Phase 1 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡